Point72 Middle East Fze Abb Vie Inc. Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $7.24 Million - $8.15 Million	-52,600 Reduced 74.72%	17,800 $2.76 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $374,052 - $433,020	2,800 Added 4.14%	70,400 $10.5 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $7.87 Million - $9.8 Million	59,400 Added 724.39%	67,600 $9.11 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $925,504 - $1.07 Million	-6,400 Reduced 43.84%	8,200 $1.31 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.02 Million - $2.42 Million	14,600 New	14,600 $0

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.